Navigation Links
China's Type 2 Diabetes Market Will Grow To $3.5 Billion In 2017
Date:8/8/2013

BURLINGTON, Mass., Aug. 8, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the type 2 diabetes therapeutic market in China, the third largest after the United States and Japan, will grow 10 percent annually, reaching $3.5 billion in 2017.  Fueling this expansion are the growing number of drug-treated patients and the increasing use of dipeptidyl peptidase-4 (DPP-IV) inhibitors, glucagon-like peptide 1 (GLP-1) receptor agonists and insulin analogues.

The Emerging Markets report entitled Type 2 Diabetes in China finds that, although further generic erosion of older oral antidiabetics is expected, recently launched DPP-IV inhibitors (Merck's Januvia/Janumet, Bristol-Myers Squibb/AstraZeneca's Onglyza, Novartis's Galvus) and GLP-1 receptor agonists (Bristol-Myers Squibb/AstraZeneca's Byetta, Novo Nordisk's Victoza) will continue to enjoy market exclusivity and garner higher patient share in China during the 2012-2017 period. Biosimilar versions of insulin analogues, both long- and short-acting, will have only a modest impact on China's type 2 diabetes market during the forecast period. Most biosimilar insulins are only fractionally less expensive than the originators, which encourages physicians and patients to stay with branded insulins. Together with the launches of additional novel agents, Western-branded therapies will consistently capture more than 70 percent of sales in China's type 2 diabetes therapeutic market by 2017.

The findings also reveal that Chinese physicians show strong interest in DPP-IV inhibitors and GLP-1 receptor agonists. DPP-IV inhibitors are favored be
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014  Decision Resources Group is launching an extension ... to now include ChinaTrack; the new capabilities track the ... interactive dashboard providing detailed brand-level share tracking and analytics. ... level. Other key capabilities of the new ... addition to end-user surveys of healthcare facilities, ChinaTrack data ...
(Date:7/31/2014)... July 31, 2014 Hovione today announced ... has successfully passed a pre-approval inspection by the US ... out by the FDA Consumer Safety Officer, Ms. Britanny ... 21 st July and concluded on the 25 th ... the principles and guidelines of Good Manufacturing Practices (GMP) and ...
(Date:7/31/2014)... , July 31, 2014 AFFiRiS ... New York results of AFF008, a Phase I ... is the first therapy against the protein alpha-synuclein, a promising ... Michael J. Fox Foundation for Parkinson,s Research (MJFF) supported the ... the press conference on the impact a disease-modifying therapy would ...
Breaking Medicine Technology:Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
... Calif. , June 3 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... will present during the Jefferies 2010 Global Life Sciences Conference.  The Alexza presentation ... ET .  The presentation will be webcast from the Grand Hyatt Hotel in ... , To ...
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that William Roberts ... Global Life Sciences Conference at 4:00 P.M. ET on Wednesday, ... in New York City . , ... Mr. Roberts also will present at the ThinkEquity Healthcare Conference at 1:30 ...
Cached Medicine Technology:Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference 2Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference 3ViroPharma to Participate in Two June Healthcare Investor Conferences 2
(Date:7/31/2014)... 31, 2014 Parker Waichman, LLP, a ... cases, comments that whistleblowers are a critical component of ... activities that may cause harm to consumers and may ... Whistleblower Appreciation Day. , According to a 2013 report ... Senate declared "National Whistleblower Appreciation Day" on July 30, ...
(Date:7/31/2014)... 31, 2014 Etymotic Research, an ... new sponsorship of the DrumLine Battle® series of ... hearing protection products ETY•Plugs® and Music•PRO® electronic earplugs. ... harmful effects of high-level sound. Etymotic will be ... the Drum Corps International Championships on August 7-9, ...
(Date:7/31/2014)... News) -- Many black women put concerns about their ... It,s estimated by the U.S. Centers for Disease Control ... in the United States are overweight or obese. Yet ... having to have their hair restyled or restraightened, the ... However, the researchers also noted a shift toward more ...
(Date:7/31/2014)... Rich Dad® Education , a leader ... benefit Habitat for Humanity. The yard sale was a success. ... of the proceeds donated to Habitat for Humanity of Lee ... the event were donated to the Habitat for Humanity ReStore ... Florida 33903. , Of the over $650, roughly $30 ...
(Date:7/31/2014)... an algorithm aimed to diagnose pediatric patients with ... (CT) scans, without affecting diagnostic accuracy, Mayo Clinic ... recently published in the journal Surgery . ... of acute abdominal pain in children. Appendicitis occurs ... pus. CT scans are often used to diagnose ...
Breaking Medicine News(10 mins):Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4Health News:Etymotic Research Becomes The Official Hearing Protection Sponsor Of DrumLine Battle 2Health News:Hairdo Trumps Exercise for Many Black Women, Study Finds 2Health News:Rich Dad Education Charity Yard Sale to Benefit Habitat for Humanity of Lee and Hendry Counties a Success 2
... announcement of the Genetics & Public Policy Center ... May 5 To "get personalized medicine right," ... need to "create and implement a reasonable and ... advanced medical diagnostics, a diverse coalition of more ...
... and cardiovascular disease in obese women, but getting started ... study by researchers at the Swedish medical university Karolinska ... more women to exercise to and from work. ... for helping populations at risk of heart disease and ...
... In support of World Asthma Day, ... partnership with Direct Relief International, a nonprofit humanitarian ... of QVAR(R) (Beclomethasone HFA), an Inhaled Corticosteroid (ICS) ... will distribute the medication to economically disadvantaged and ...
... Bates County Memorial Hospital (BCMH), a ... the MedGenix financial and patient management system. The MedGenix ... cycle management and financial accounting modules. The MedGenix ... Systems (CHS), based in Springfield, MO. Founded in 1992, ...
... goals to expand nationwide, Wellspring recently ... Bill will spearhead the newly formed Network Development Division that ... 2010. He is responsible for making Wellspring a household name ... Fortune 100 senior executive with healthcare, insurance and leading technology ...
... May 5 Air Products (NYSE: APD ... U.S. home infusion therapy services business and some elements ... OptionCare Enterprises, Inc., a subsidiary of Walgreen Co. ... Air Products, ownership interests in certain of the companies ...
Cached Medicine News:Health News:Overhaul of Genetic and Other Advanced Diagnostic Testing Regulations Necessary for Personalized Medicine, HHS Secretary Told 2Health News:Overhaul of Genetic and Other Advanced Diagnostic Testing Regulations Necessary for Personalized Medicine, HHS Secretary Told 3Health News:Extra support helps obese women cycle to and from work 2Health News:Teva Respiratory Supports World Asthma Day by Providing FREE QVAR(R) to Those Who Need It Most 2Health News:Teva Respiratory Supports World Asthma Day by Providing FREE QVAR(R) to Those Who Need It Most 3Health News:Teva Respiratory Supports World Asthma Day by Providing FREE QVAR(R) to Those Who Need It Most 4Health News:Teva Respiratory Supports World Asthma Day by Providing FREE QVAR(R) to Those Who Need It Most 5Health News:MedGenix Financial Information System Selected by Bates County Memorial Hospital 2Health News:Wellspring Hires William Young and Prepares for Nationwide Expansion 2Health News:Air Products Sells Major Portion of U.S. Healthcare Operations to Walgreens 2
... The Leica RM2235 is a robust ... of primarily biological specimens embedded in ... backlash-free precision micrometer feed system ensures ... even when sectioning harder tissues. The ...
... biomedical and industrial applications, the Leica SM2400 ... of applications in all laboratories where paraffin ... sectioned. Its sturdy construction lends it qualities ... features of the system, such as a ...
... Automatic microtome with vibrating blade for fixed and ... as for non-biological specimen in material science ... of blade amplitude between 0,1 and 1,2 mm ... parameters can be set independently from each other. ...
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
Medicine Products: